Swiss agrochemical maker Syngenta AG used an upbeat earnings report to bolster its case against a $45 billion takeover bid from U.S. rival Monsanto Co., saying the numbers prove it can stand alone with a product pipeline stretching to the end of the decade.
“A lot of the new products are starting to pay off,” Chief Executive Officer Mike Mack said in a phone interview on Thursday, adding that the increase in profit and sales in the first half is the best answer to Monsanto’s unsolicited offer. “And the pipeline in 2016 and beyond is going to steer this company to the end of the decade.”
